Shuttle Pharmaceuticals Holdings, Inc.
SHPHHealthcare|Drug Manufacturers - Specialty & Generic|US
$5.58
+0.55 (+10.81%)
Tangible Book / Share
$10.38
Cash / Share
$0.09
About
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Stock Price
-78.1%(1Y)
1M
+0.6%
3M
+28.1%
6M
-18.9%
YTD
-69.0%
1Y
-76.7%
3Y
-99.5%
5Y
-100.0%
Pipeline Summary
1 total trials0
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
Terminated: 1
Key Facts
Market Cap$26.6M
Employees2 (-78% YoY)
CEOChristopher Robert Cooper
IPO DateAug 31, 2022
Beta1.14
52-Week Range$2.576 – $44.4
Avg Volume1,527,736
ExchangeNASDAQ
Websiteshuttlepharma.com
Ownership
Float99.8%
Shares Outstanding4.8M
Recent Insider Trades
HRT FINANCIAL LPSELL
Jul 13, 20261,033 shares @ $4.67
HRT FINANCIAL LPSELL
Jul 14, 202682,116 shares @ $4.48
HRT FINANCIAL LPBUY
Jul 10, 2026731 shares @ $3.11
HRT FINANCIAL LPBUY
Jul 9, 20268,266 shares @ $3.38
HRT FINANCIAL LPOTHER
Jul 9, 20260 shares
Peers
Recent News
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Update
Oct 2, 2026 · defenseworld.net
Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter
Aug 28, 2026 · newsfilecorp.com
Data last updated: Nov 9, 2026, 04:33 AM